Skip to content

Ropivacaine Volume for Ultrasound-guided Retrograde Infraclavicular Brachial Plexus Block

Ropivacaine Volume for Ultrasound-guided Retrograde Infraclavicular Brachial Plexus Block

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01334619
Enrollment
30
Registered
2011-04-13
Start date
2010-03-31
Completion date
2010-05-31
Last updated
2011-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Extremity Injury Trauma

Keywords

Anesthetic techniques,regional, Drug delivery,volume, Anesthetic, local: ropivacaine

Brief summary

The retrograde infraclavicular brachial plexus block has been proved an effective and safe approach. Realtime ultrasound guide will facilitate a successful peripheral nerve block. The purpose of this study was to determine the medium effective volume required to produce an effective retrograde infraclavicular block using an ultrasound (US)-guided technique.

Detailed description

Thirty adults undergoing elective upper limb surgery received an US-guided retrograde infraclavicular block. The initial concentration of 0.5% ropivacaine injected was 30 ml, which was subsequently varied at a ratio of 1: 1.2 for each consecutive patient according to the response of the previous patient. The medium effective volume (EV50) was determined using the Dixon and Massey up-and-down method. The effective volume in 95% of patients (EV95) was calculated using probit regression.

Interventions

PROCEDUREappropriate volume of 0.5% ropivacaine

initial concentration: 30 ml, subsequently varied at a ratio of 1: 1.2 for each consecutive patient according to the response of the previous patient, until 5 up-and-down cycles completed.

Sponsors

Beijing Jishuitan Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Elected upper extremity operations * BMI 17\ 30kg/m2 * ASA I/II

Exclusion criteria

* Infection at injection site * Sepsis * Coagulation Dysfunction * Phrenic nerve palsy * Pneumothorax * Recurrent laryngeal nerve palsy * Clavicle fracture combined with nerve damage

Design outcomes

Primary

MeasureTime frameDescription
VAS of brachial plexus innervated area20 minuteseffect and side effects of the present block approach for brachial plexus.

Secondary

MeasureTime frameDescription
medium effective ropivacaine volumeabout 2 monthsThe initial concentration of 0.5% ropivacaine injected was 30 ml, which was subsequently varied at a ratio of 1: 1.2 for each consecutive patient according to the response of the previous patient. The medium effective volume (EV50) was determined using the Dixon and Massey up-and-down method. EV95 was calculated using probit regression.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026